People of European descent have the highest incidence of Cystic Fibrosis of any ethnic group in the world. 4% of people who are of European descent carry an allele for cystic fibrosis. This means that the United States and Europe have the highest rates of cystic fibrosis. It also means that these countries are the most suitable for conducting cystic fibrosis research.
One in nineteen people in Ireland are cystic fibrosis carriers which is believed to be the highest carrier rate in the world. Three out of every ten thousand people in Ireland suffer from cystic fibrosis. This rate is nearly four times that of the average rate in the United States and Europe.
Because Ireland offers such a substantial population for conducting related research Java Clinical has developed a specialised interest in the area of cystic fibrosis studies. The large patient population has meant that Java Clinical Research has had ample opportunity to develop its experience and expertise.
By working closely with Ireland’s leading researchers Java Clinical has developed strong working relationships and close connections with all of the CF research specialist units in the country.
With such strong ties already established, Java Clinical can reach study recruitment targets and achieve timeline targets with ease. As a result, Java has been able to carry out many successful studies with both paediatric and adult CF patient populations.
Still, Ireland as a whole has a relatively small population. This is why Java Clinical Research has taken the time to build up strong relationships with research centres across Europe and has a comprehensive data base of areas suitable for cystic fibrosis clinical trials in Ireland and across Europe.